First Implantable artificial heart gets FDA’s approval
The FDA approved the first completely implantable artificial heart, AbioCor, for patients with severe heart issues unsuitable for transplants. It's restricted to 4,000 units annually, targeting end-stage patients. The device extends life by an average of 4.5 months, with some living up to 17 months. It's a 2-pound mechanical heart, requiring patients to be at least 6 feet tall and 170 pounds. Costing around $250,000, its insurance coverage is unclear. The approval aims to encourage further technological refinement.
Reference News
The FDA approved the first completely implantable artificial heart, AbioCor, for patients with severe heart issues unsuitable for transplants. It's restricted to 4,000 units annually, targeting end-stage patients. The device extends life by an average of 4.5 months, with some living up to 17 months. It's a 2-pound mechanical heart, requiring patients to be at least 6 feet tall and 170 pounds. Costing around $250,000, its insurance coverage is unclear. The approval aims to encourage further technological refinement.